TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›BTSG›Financials
Annual statements · SEC XBRL · FY2022 – FY2025

BrightSpring Health Services, Inc. (BTSG) financials

Income statement

BrightSpring Health Services, Inc. (BTSG) income statement, annual, from SEC filings
Fiscal yearFY2022FY2023FY2024FY2025
Revenue$7.72B$7.69B$10.1B$12.9B
Revenue growth—-0.4%31.0%28.2%
Gross profit$1.35B$1.14B$1.27B$1.52B
Gross margin17.5%14.8%12.6%11.8%
Operating income$188M$58.1M$108M$295M
Operating margin2.4%0.8%1.1%2.3%
Net income-$53.9M-$155M-$18.1M$191M
Net margin-0.7%-2.0%-0.2%1.5%
EPS (diluted)-$0.46-$1.31-$0.09$0.87

Cash flow

BrightSpring Health Services, Inc. (BTSG) cash flow, annual, from SEC filings
Fiscal yearFY2022FY2023FY2024FY2025
Operating cash flow-$4.65M$211M$23.8M$490M
Capital expenditures$70.1M$73.5M$80.9M$95.5M
Free cash flow-$74.8M$137M-$57.1M$395M
Share buybacks—$650K$650K$43.2M

Balance sheet

BrightSpring Health Services, Inc. (BTSG) balance sheet, annual, from SEC filings
Fiscal yearFY2022FY2023FY2024FY2025
Cash & equivalents—$13.1M$61.0M$88.4M
Total assets—$5.53B$5.93B$6.41B
Total liabilities—$4.92B$4.27B$4.53B
Long-term debt—$3.33B$2.56B$2.46B
Shareholders' equity$755M$585M$1.65B$1.88B
Retained earnings—-$200M-$222M-$74.6M
Shares (wtd avg diluted)118M118M193M220M

Every figure is extracted from BrightSpring Health Services, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

What is BrightSpring Health Services, Inc.'s annual revenue?
BrightSpring Health Services, Inc. (BTSG) reported $12.9B of revenue for fiscal year 2025 — up 28.2% from $10.1B in FY2024, per its annual report filed with the SEC.
Is BrightSpring Health Services, Inc. profitable?
Yes — BTSG earned $191M of net income in FY2025, a 1.5% net margin, per SEC filings.
What is BrightSpring Health Services, Inc.'s free cash flow?
$395M in FY2025 (operating cash flow $490M minus $95.5M of capital expenditures), from the SEC cash-flow statement.
Does BTSG pay a dividend?
BrightSpring Health Services, Inc. reported no cash dividends paid in FY2025, per its SEC cash-flow statement.
Full BTSG analysis — verdict, score & filings →Is BTSG a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.